John Militello, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 1,060 shares at $3.07 ($3K) on 2025-08-18, disclosed to the SEC on 2025-08-20.
Open-market sale of $3k RCKT by See Remarks. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.07 | 699 | $2K | 66.5% |
| 2 | $3.00 | 361 | $1K | 33.5% |
| Total | $3.05 avg | 1,060 | $3K | 100% |
| Filing → |
| RCKT | SELL | 2026-02-20 | $4K | — | Filing → |
| RCKT | SELL | 2026-02-18 | $12K | — | Filing → |
| RCKT | SELL | 2025-11-20 | $3K | — | Filing → |